Kenvue Inc. Common Stock vs Schwab US Dividend Equity ETF — how do they compare? Kenvue Inc. Common Stock trades at $17.7 (market cap $34.06B), while Schwab US Dividend Equity ETF trades at $33.04 (market cap $110.56B). The key difference: Schwab US Dividend Equity ETF is far larger — about 3.2× Kenvue Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while Schwab US Dividend Equity ETF pays none. Which is the better fit depends on your goals.
| KVUE | SCHD | |
|---|---|---|
Market Cap | $34.06B | $110.56B |
Volume | 23,267,228 | 23,539,168 |
Sector | Consumer Staples | Broad Market / Factor |
52-Week High | $19.83 | $35.21 |
52-Week Low | $14.11 | $26.44 |
Enterprise Value | $41.56B | — |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 62 Days |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
SCHD trades at $33.15, up 1.53% today, with a bullish technical signal despite mixed moving averages. The ETF has outperformed the S&P 500 by nearly 10 percentage points in 2026, with recent dividend growth attracting income-focused investors. Technical indicators show neutral oscillators but strong trend momentum with ADX readings above 60.
SCHD offers dividend growth potential with lower fees than competitors, though its defensive tilt may lag in growth markets. Key risks include interest rate sensitivity and methodology constraints that excluded high-performing stocks like Broadcom. The current pullback from August highs presents a potential entry point for long-term dividend investors.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →SCHD is an ETF that tracks the Dow Jones U.S. Dividend 100 Index. It selects high-quality companies with a consistent track record of paying dividends, focusing on financial strength metrics like cash flow to total debt and return on equity, and excluding REITs. The fund aims to provide both income and capital appreciation, making it a popular choice for long-term, dividend-focused investors.
Read more on SCHD →